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CHAPTER I 
INTRODUC~·ION 
The knowledge that pyruvic acid is a highly re-
active biochemical intermediary of carbohydrate, protein 
and fat metabolism has stimulated this research. It is 
believed that a diseased organism is in a state of con-
siderable stress and strain in which the need for large 
quantities of energy are required. This energy is sup-
plied by the oxidation of protein, fat and carbohydrate, 
particularly the latter. Thus, an increase in the energy 
requirements of the body should, in the opinion of the 
investigator, be met by an increase in the oxidation of 
available sources of energy, with an accompanying increase 
in the concentration of blood pyruvate. It was further 
considered that the formulation of a diagnostic aid of 
clinical importance could be developed by noting the 
concentration of this biochemical substance in these dif-
ferent pathological states. In taking this view, the 
scope of this problem was not to establish a cause of any 
deviation from normal that may have been present in these 
various diseases but to determine if any abnormal quan-
tities of pyruvic acid did prevail .. 
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In searching the literature, it was found that very 
little work has been published in which pyruvic acid 
determinations were made in various pathological conditions. 
The reports which have been published in the literature are 
conflicting and scanty (1, 4, 7, 14). 
Determinations of lactic acid were carried out in 
conjunction with pyruvic acid because of their direct rela-
tionship with each other in body metabolism. Hemoglobin 
and erythrocyte counts were performed because the high re-
activity of pyruvic acid depends greatly upon the oxygen 
supply (13). Leucocyte counts were made to complete the 
blood picture .. 
CHAPTER II 
LITERATURE SURVEY 
Carbohydrate metabolism was not clearly understood 
until the year 1897 when Hans and Buchner made the key 
discovery of the use of cell free yeast extract to aid in 
the isolation of carbohydrate intermediaries. This was 
soon followed by the isolation of hexose phosphate by 
Harden and Young in 1905 (3). The discovery of this first 
intermediate co~pound of carbohydrate metabolism set a 
score of researchers working on the problem of finding 
carbohydrate intermediaries. Baldwin (3) has stated that 
it is impossible to give an accurate historical account of 
subsequent ~rork on fermentation and the isolation of 
intermediates of carbohydrate metabolism. A number of 
mistakes were made and rectified by researchers all over 
the world, many being made simultaneously. 
Dakin and Dudley in 1913 were the first to describe 
a procedure for the determination of pyruvic acid in blood. 
Smedley and MacLean (15) reported a method in the same year, 
but it was inadequate for clinical purposes. Dakin and 
Dudley were also the first to use nitrophenylhydrazine in 
their method. These authors noted that pyruvic acid 
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hydrazone could be separated from other hydrozones by 
treatment with 10 percent sodium carbonate solution. 
Further treatment with sodium hydroxide produced a red 
color in direct proportion to the amount of pyruvate 
present. These principles have since been applied by Lu 
(14) and Beuding and Wortis (5) in their modifications 
of the analysis of pyruvic acid. 
Lu 1 s method employs the basic principles of Dakin 
and Dudley, and represents a great advancement in tech-
nique by the use of smaller quantities of blood. She did, 
however, retain three extractions with ethyl acetate and 
three with sodium carbonate. Friedman and Haugen (8) 
eliminated these six extractions without loss of accuracy 
and specificity. They used one complete extraction with 
ethyl acetate, and one with sodium carbonate solution. 
When the procedure is carried out in this manner, the 
hydrozones of glyoxals and aldehydes are extracted only 
slightly, while the hydrazone of pyruvic acid is extracted 
almost quantitatively. The hydrozones of glyoxals and 
aldehydes tend to form some salts with the 10 percent 
sodium carbonate solution, thus their interfering effects 
are minimized by reducing the number of extractions. 
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CHAPTER III 
PROCEDURES 
The Lumetron Photoelectric Colorimeter was used for 
the pyruvic acid and lactic acid determinations. The 
method for pyruvic acid was that of Friedman and Haugen (11), 
briefly outlined above. 
A standardization curve was constructed by using 
redistilled C.P. Eastman pyruvic acid, collecting that 
portion that distilled between 64 to 67 degrees centigrade 
at 13 mme of mercury in vacuu~, using a water pump for the 
vacuum. Ten ml. of the middle portion of the distillate 
were placed into a tared 50 mla beaker and the contents 
weighed. The difference in weight, 14.018 Gm. in a liter 
or 14.018 mg./ml., was taken as the standarde 
The pyruvic acid was transferred quantitatively to 
a liter volumetric flask and diluted to volume. Two diluted 
standard solutions were then prepared from this stock 
solutione 
1. Solution A.--Ten ml. of the standard stock solu-
tion were placed in a 200 ml. volumetric flask 
and diluted to volume, giving a concentration 
of 0.7 mg./ml. 
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2e Solution B .. --Ten ml. of solution A were placed 
in a 100 ml. volumetric flask and diluted to 
volume, giving a concentration of 0.07 mg./ml. 
The following amounts of the standard solutions 
and B were transferred to 100 ml. volumetric flasks and 
diluted to volume., 
Amount Used mg .. /100 mL. of Blood 
1 ml. of B 0.,07 
2 ml .. of B 0.,14 
4 ml. of B 0 .. .56 
2 ml .. of A 1 .. 4 
4 ml .. of A 2.,8 
6 ml .. of A 4 .. 2 
8 ml .. of A .5 .. 6 
10 ml. of A 7 .. 0 
The C .. P .. ethyl acetate used i'lias dehydrated and 
A 
purified by extracting three times with 0 .. 1 its volume of 
saturated solution of calcium chloride. Two hundred grams 
of anhydrous sodium sulfate vtrere added for each liter of 
ethyl acetate, and allowed to stand several hours with 
frequent shaking. It was then distilled, and the portion 
coming over at 73 to 78 degrees centigrade 1'1Tas collected 
and used. 
The Lumetron Photocolorimeter was standardized 
setting the galvanometer at 100 percent transmission and 
using filter .520. 
Method Used for the Analysis 
Five ml .. of each of the pyruvic acid standard dilu-
tions were placed in a test tube and 25 ml. of 10 percent 
trichloroacetic acid (freshly prepared) were added to each 
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tube with thorough mixing. Three ml. of this mixture were 
then transferred to a test tube containing 1 ml. of 0.1 
percent 2,4-dinitrophenylhydrazine in 2N hydrochloric 
acid and allowed to stand ten minutes. Eight ml. of ethyl 
acetate were then added to the test tube and mixed by 
passing a stream of air through the mixture for two minutes. 
Six ml. of 10 percent sodium carbonate were then added to 
the contents of the tube and again mixed by passing a 
stream of air through the mixture for two minutes. Five 
ml. of the aqueous phase were pipetted into a Lumetron 
absorption tube, and 5 ml. of 1.5N sodium hydroxide were 
added to the contents and allowed to stand ten minutes 
before reading in the Lumetron Photoelectric Colorimeter$ 
The procedure for the unknown bloods was conducted 
as described above using 2 ml. of oxalated blood which was 
deproteinated with 10 ml. of 10 percent trichloroacetic 
acid (freshly prepared). This was then centrifuged and 
2 ml. of the supernatant liquid was used for the analysis. 
Lactic Acid Procedure 
One ml. of oxalated blood and 6 ml. of water were 
placed into a test tube. A control containing 7 ml. of 
water was run simultaneously with each group of unknown 
blood samples. One ml. of 6 percent metaphosphoric acid 
was added, mixed, and centrifuged. Four ml. of the clear 
supernatant liquid were transferred by pipette to another 
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centrifuge tube to which was ad_ded 1 ml. of 15 percent 
copper sulfate solution and about 1 Gm. of calcium hydroxide. 
These tubes were stoppered and p~aced in the refrigerator 
for thirty minutes. They were th~ centrifuged and the 
supernatant liquid dec~nted and centrifuged again. One 
ml~ of this clear liquid was placed in a test tube im-
mersed in ice water, and J ml. of concentrated sulfuric 
acid added while stirring. One-tenth ml. of 20 percent 
alcoholic solution of hydroquinone was then added and the 
contents mixed. The solution was then placed in a boiling 
water bath for twenty minutes, then cooled in ice water 
for two minutes. Five ml. of water were then added, stir-
ring until vTell mixed. The tubes were then allowed to 
stand until all gas bubbles had escaped, and the solution 
then transferred to a Lumetron absorption tube. Percent 
transmission of the unknown was read against a zero blank 
solution setting the galvanometer at 100 percent trans-
mission using filter 420. The milligram percent of lactic 
acid was then found by reading a precalibrated graph. 
Hemoglobin determinations were conducted according 
to the Leitz Photoelectric Colorimeter Hand Book using the 
Leitz Photoelectric Colorimeter. 
Erythrocyte and leukocyte counts were made according 
to an accepted clinical method using the Spencer Bright 
Line Hemocytometer$ 
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CHAPTER IV 
RESULTS 
Blood was obtained from eighty-nine fasting hospi-
talized patients of ages ranging from twenty-five to eighty-
seven years. The results are presented in tabular form 
according to the disease diagnosed by the attending physi-
cian. Normal values chosen for hemoglobin and erytr~ocyte 
counts for both men and women were 15 Gm./100 ml. of blood 
and 4,500,000 to 5,500,000 per cu. mm., respectively. 
Normal values for pyruvic acid were 0.6 to 1.2 mg./100 ml. 
of blood (11). The lactic acid normal was taken as 5 mg. 
to 20 mg./100 mle of blood (11). 
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TABLE 1 
RESULTS OF THE DETERMINATIONS OF PYRUVIC ACID, LACTIC 
ACID, HEMOGLOBIN, ERYTHROCYTE, AND LEUKOCYTE COUNTS 
IN PATIENTS viTTH NEO-PLASTIC DISEASES 
Normal Values 
1.5 Gm. /100 m1. I 4, .500, 000 to ~----- .5, 000 to 
.5,.500,000 cu.rnm. 10,000 cu.mm. 
---------------4-----R.B.C. Count W.B.C. Count Hemoglobin 
0$6 to 1.2 .5 to 20 
mg./100 m1. mg./100 ml • 
Pyruvic Acid Lactic Acid 
7.* 1 2,690,000 r-17,900 1 0.7 ·1 .. 9.4 I 3,91o,ooo 6,9oo o~s.5 * 
11.0 3,960,000 13,.500 0.43 * 
11.0 .5,.590,000 18,8.59 o.o .. 
13.9 .5,910,000 7,9.50 o.o * 
12.8 6,320,000 8,499 0&1.5 * 
12e6 4,960,000 7,4.50 0.31 * 
12.6 4,210,000 9,0.50 o.o 14.0 
12.8 1 4,070,000 6,8.50 0.0 9 • .5 
11.3 4,210,000 .5,6.50 o.o 18~.5 
7.0.5 3,310,000 7,700 o.o 13.4 
10.6.5 4,4.50,000 7,6.50 o.o 1.5.9 
9.0 2,980,000 7,8.50 ! 0 • .5.5 12.2 
5.6 2,290,000 12,200 o.o * 
13.9 5,150,000 9,500 I o.o 10.0 
7J~ * ~(o 0 • .5.5 * 
12. 6 * -11- 0. 0 ~l-
*Results not obtained. 
J-1 
J-1 
-15 Gm./100 ml .. 
Hemoglobin 
15 
9.3 
13 
15.3 
9.15 
15.8 
"1 3 0 
_J.. • / 
15.3 
13.0 
17.6 
lLO 
* 
15.8 
15.3 
13.0 
13 .. 65 
14.1 
12 
12.35 
15.3 
T.ABLE 2 
RESULTS OF THE DETER~ITNATIONS OF PYRUVIC ACID, LACTIC 
ACID, HENOGLOBIN, ERYTHROCYTE, AND LJ<:UKOCYTE COUNTS 
IN PATIENTS WITH CARDIAC DISEASES 
Normal Values 
- r--4,500,000 to 5,000 to 0.6 to 1.2 5,500,000 cu.mm. 10,000 cu.mm. mg./100 mle 
R.B.C. Count 11!. B • C • Count Pyruvic Acid 
-· 
-11- * 0.31 
* * 0.31 
4,750,000 11,050 o.o 
4,380,000 11,600 0.15 
-~~ ~~ 0.43 
* * o.o 
* * o.o ! 
* * o.o 
* 
~~- 0.,55 
6,860,000 11,250 0$5 
3,710,000 9,100 o.o 
6, oL~o, ooo 12' 1+50 o.o 
7,320,000 10,850 o.o 
1.+-, 910' 000 7,650 o.o 
4,950,000 12,000 o.o 
6,020,000 8,600 o.43 
4,820,000 13' 4·50 0.31 
5,050,000 9,800 0.85 
4,250,000 4,800 o.o 
4,810,000 17,900 l o.43 
-
*Results not obtained. 
5 to 20 
mg./100 ml. 
Lactic Acid 
* 
* 
i~ 
~· 
* 
. . 
~to 
* 
~~-
* 
* 
* 
~t 
-~~ 
* 
* 
* 
* 
it> 
* 
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T'ABLE 2--Continued 
Normal Values 
15 ---G-m-. /_l_O_O_m--1-.---,--4-, 5_0_0_,_0_0_0_t_o_---r-_ 5 , 0 0 0 to --0-. 6-t-; 1. 2 T 
5,500,000 cu.mm. 10,000 cu.mm. mg./100 ml. 
Hemoglobin ! R.B.C. Count. W.B.C. Count Pyruvic Acid 
14.8 
12 .. 5 
11.8 
11.8 
14o55 10~ 65 I 
13.0 _ 
~f 
5,990,000 
5,070,000 
3,820,000 
6,020,000 
3,990,000 
3,890,000 
~i' 
10,050 
10,800 
8,950 
5,950 
14, 650 
8,100 
o. 0 
o. 0 
o. 0 
o.o 
o.o 
o.o 
0.15 
5 to 20 
mg. /100 mL 
Lactic Acid 
* 
* 10.6 
11.2 
15.2 
~~-
7 
f-l 
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TABLE 3 
RESULTS OF THE DETE~INATIONS OF PYRUVIC ACID, LACTIC 
ACID, HEMOGLOBIN, ERYTHROCYTE, AND LEUKOCYTE COUNTS 
IN PATIENTS vHT'H DIABETES MELLITUS 
Normal Values 
15 Gm. /100 ml. 4,500,000 to 5,000 to o. 6 to 1.. 2 ..
5,500,000 cu.mm. 10,000 cu.mm. mg. /100 ml. 
Hemoglobin R.B.C. Count W.B.C. Count Acid Pyruvic 
- -
* 5,150,000 7' 250 o.o 
"*' 
5,440,000 9,950 0.0 
14.8 * * o.o ll. 6 4,070,000 9,050 o.o 
13.9 5,220,000 10,000 o.o 
14.3 5,190,000 8,150 o. 0 
14.1 5,610,000 7,800 o. 0 
14.4 .3,.340,000 11,750 o.o 
12.47 4,690,000 8,200 o.o 
8.8 2,740,000 9,000 o.o 
*Results not obtained. 
-~ 
5 to 20 
mg./100 ml. 
Lactic Acid 
* 
* it 
~~· 
14.7 
11.6 
11.6 
10.6 
15.2 
10.6 
f-1 
.{::::' 
•• 
TABLE 4 
RESULTS OF 1'HE DETERMINATIONS OF PYRUVIC ACID, LACTIC 
ACID) HEMOGLOBIN, ERYTHROCYTE, AND LEUKOCYTE COUNTS 
IN PATIENTS WITH DEGENERATIVE DISEASES 
--
--·--·-····--- --------- -~--·---- ~ 
Normal 4,500,000 to 5,000 to 0 .. 6 to 1 .. 2 
Values 15 Grn./100 rnl. 5,500,000 cu.mm. 10,000 cu.mm. mg. /100 mL 
-
Prenicious 
Anemia •....•• 5 .. 25 1,620,000 .3,850 0.15 
Prenicious 
Anemia ......• 7 .. 05 2,610,000 10,550 o.o 
Anemia (undif-
ferentiated). * .3,160,000 4,800 o.o 
Urernia" ~ .. ., , . Q (II ill 10.,4 4,570,000 11,750 o.o 
Uremia~,~~ . ., .. ~ e " " 9.5 .3,590,000 15,000 o.o 
Uremia and 
Anemia •...... 6.92 1,920,000 9' .35 0 o.o 
Cirrhosis of 
Liver. Gl ., ... 8 ~ • lLO .3,.3.30,000 8,150 o.o 
Cerebrovascular 
Accident ....• * * * 0 .. .31 Cerebrovascular 
Accident •..•• 14.55 5,180,000 6,850 o.o 
Common Duct 
Stone$ 0.,. o " "$ $ 14 • .3 5,420,000 9,200 o.o 
Rheumatoid 
Arthritis •..• 10 .. 65 4,210,000 10,000 o.o 
-
*Results not obtained. 
~ ·~ 
5 to 20 
mg./100 ml 
# 
# 
14.0 
-~~ 
18.5 
17.2 
1.3 .. 4 
10.6 
11 .. 0 
10.,6 
12.8 
f-' 
\.T\ 
TABLE 5 
RESULTS OF ~('HE DETERMINATIONS OF PYRUVIC ACID, LACTIC 
ACID, HEMOGLOBIN, ERYTHROCYTE, AND LEUKOCYTE COUNTS 
IN PATIENTS ~~TH INFECTIOUS DISEASES 
Normal 4,500,000 to 5,000 to 0.6 to 1.2 
Values 15 Gm. /100 ml. 5,500,000 cu.mm. 10,000 cu.mm. mg./100 ml. 
Pneumonia ...•.•• 12.35 4,110,000 12,350 o.o 
Pneumonia •.....• 11.5 4,690,000 6,400 o.o 
Pneumonia •....•• 13.4 3,960,000 14,200 o.o 
Pneumonia •.....• 7.25 3,120,000 8,850 0.31 
Pneumonia •.....• 13.4 4,290,000 -~~ 1.85 
Pneumonia •....•• 13.4 4,710,000 5,900 o.o 
Pneumonia ......• 8.05 ~~ * o.o Pneumonia •.....• 13 .. 9 * ~~ o.o Hepatitis ......• 15.8 5,710,000 9,050 1.4 
Hepatitis •.....• 13.0 4,240,000 4,650 0.43 
Hepatitis and 
Pregnancy ....• 9.15 5,450,000 7,900 o.o 
Pyelonephritis •• 13 .. 4 4,440,000 11,850 o.o 
Dermatophytosis. 14.5 4,4LJ,o,ooo 8,800 o. 0 
Luetic Heart •.•• 11.35 4,280,000 8,100 o.o 
Pulmonary 
Ernphy s em a ....• 11.8 4,120,000 9,750 0.3 
Pulmonary 
Emphysema •.... 10 .. 65 3,460,000 15,850 0.43 
Pulmonary 
Tuberculous ••• 8.2 4,740,000 8,'-ljO o.o 
-------
------------------- -·--------·---- ~---------------
*Results not obtained. 
5 to 20 
mg./100 ml 
* 16.5 
9.0 
17.8 
14.7 
17.8 
-~~ 
11.6 
* 15.0 
14.7 
12.8 
11 .. 6 
18.5 
11.6 
17.8 
17.3 
1--' 
()'\. 
r"''", ' ' 
TABLE 6 
RESULTS OF ~PRE DETERHINATIONS OF PYRUVIC ACID, LACTIC 
ACID, HEMOGLOBIN, E..K.YTHROCYTE, AND LEUKOCYTE COUNTS 
IN PATIENTS WITH MISCELLANEOUS DISEASES 
-
Normal 4,500,000 to 5,000 to 0.6 to 1.2 
Values 15 Gm. /100 mL 5,500,000 cu.mm .. 10,000 cu.mm. mg./100 ml. 
Hysterectomy •.• 10.65 * * o .. o Asthn1a • .... !) I) ~ 01 IDe * ~~- ~~ 0.85 
Asthma ......... lJ.65 5,220,000 9,JOO 0.15 
Pregnancy ...••• 12.J5 4,450,000 14,200 o.o 
Pregnancy •....• 12 .. 17 3,790,000 5,200 o.o 
Common Duct 
Stone.*~O!*O~~ 14.J 5,420,000 9,200 o.o 
Common Duct 
Stones~$ o, <!I , Cit 11.0 J,J60,000 5,750 o.o 
- - ~---------
*Results not obtained. 
5 to 20 
mg./100 ml 
* 
12.8 
15.9 
11.2 
9,5 
10 .. 6 
lJ .. 4 i-l 
--..:! 
i/ 
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CHAPTER V 
DISCUSSION 
The pyruvic acid concentration in patients with 
various pathologies are presented in Tables 1, 2, 3, 4, 
5, and 6. The majority of cases studied had a 0 percent 
pyruvic acid or an insignificant a~ount. There were a 
fevJ isolated cases which were within the normal range, 
but they i'lfere believed to be of no practical value. The 
hemoglobin concentration in the majority of cases studied 
was below the set standard. Thirty of the total nmnber 
of patients studied were found to have normal, or above, 
erythrocyte counts. Lactic acid concentration in all 
patients in this study fell within the normal range. 
The expectation of some correlation between the 
tests performed was not realizede It was particularly 
disappointing when no relationship was found between the 
hemoglobin and pyruvic acid concentration. It is the 
opinion of this investigator that the finding of normal 
concentrations of lactic acid is indicative of the fact 
that the pyruvic acid was not being converted immediately 
to lactic acid .. 
18 
f,;, 
L___ 
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The expectation of obtaining high pyruvic acid 
levels was backed by the reports of Amatuzio, et al. (1, 2), 
Goldsmith (9), Earl, et al. (6), and Havel, et al. (10). 
In diabetes mellitus, Bueding (5) and Hill (12) ob-
tained normal fasting pyruvic acid levels with an increase 
after the ingestion of glucose and the administration of 
insulin. These reports, however, were contrary to the 
findings of Amatuzio, et aL ( 1), i'>rherein they found no 
increase of pyruvic acid after the administration of insulin, 
but obtained normal fasting pyruvic acid levels. These 
authors also recorded increased pyruvie acid levels in liver 
coma. Liver coma was not studied in the course of this 
research, but the results of two cases of hepatitis were 
recorded. One of these patients had a pyruvic acid con-
centration of 1 .. 4 mg., and a hemoglobin concentration of 
15.8 Gm. The other had a 0643 mg .. percent of pyruvic acid 
and a hemoglobin concentration of lJ.O Gm., thus indicating 
the presence of pyruvic acid but not in increased quantities. 
Friedman and Haugen in 1942 (?) reported that the 
use of anti-coagulants and an anti-enzyme would bring about 
an immediate loss of pyruvic acid.. This is, however, 
contradictory to the results obtained by Goldsmith (9), 
Bueding and vJortis (4, 5), and Earl, et ale (5), wherein 
they obtained high levels of pyruvic acid in their experi-
ments when using an anti-coagulant or anti-enzyme, or 
both .. 
20 
It is the opinion of this investigator that due to 
the conflicting results that have been reported in the 
literature, and the negative results obtained in this 
experiment, more basic research should be conducted on 
this subject. 
1 
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CHAPTER VI 
SUM1~EY 
Determinations of blood pyruvic acid, lactic acid, 
hemoglobin, and erythrocyte counts were performed on eighty-
nine fasting hospitalized patients with various pathologies. 
The methods used for the determinations are described 
in detail, and the results obtained are presented in 
separate tables according to the general classification of 
the disease as diagnosed by the attending physician. 
The results obtained and recorded for pyruvic acid 
were 0 percent, or an insignificant amount. The hemoglobin 
and erythrocyte counts, according to the standards of this 
experiment, were subnormal in over 50 percent of the cases 
studied. Lactic acid concentrations were found to be with~ 
in the normal range in all patients included in this 
investigation. 
It is the opinion of this author that more basic 
research on the determination of pyruvic acid in the blood 
should be conducted before an interpretation of clinical 
significance can be established. 
21 
i36i34 
1 
---------------------------------------J 
BIBLIOGRAPHY 
,._ . 
./;'';"}: 
__________ ___._jjt?:. 
List of References 
1. Amatuzio, D. s., Shrifter, N., Stutzman, F. L., and 
Nesbitt, s., Blood pyruvic acid response to intra-
venous glucose or insulin in the normal and in 
patients with liver disease and with diabetes 
mellitus. J. Clin. Investigation, }!: 751. 1951. 
2. Amatuzio, D. S., and Nesbitt, S., Blood pyruvate 
concentration in liver coma. J. Clin. Investigation, 
~: 1486.. 1950. 
Baldwin, E. 
Cambridge: 
Dynamic Aspects of Biochemistry. 
The Harvard University Press, 1952. 
4. Bueding, E., and Wortis, H., The stablization and 
determination of pyruvic acid in blood. J. Biol. 
Chern., l}l: 585. 1940. 
5. Bueding, E., and Wortis, H., Pyruvic acid metabolism 
j_n diabetes mellitus. Am. J. Med. Sci. , 204: 838. 
1942. 
6. Earl, C. J., El Hawary, M. F. s., and Thompson, R. 
H. s., Blood pyruvate levels in subacute combined 
degeneration of the cord and the effect of vitamin 
B-12 therapy. Lancet, 1: 114. 195J. 
7. Friedman, T., and Haugen, G. E., Collection of blood 
for the determination of pyruvic acid. J. Biol. 
Chern., 144; 156. 1943. 
8. Friedman, T., and Haugen, G. E., The determination 
of pyruvic acid in blood and urine. J. Biola Chern., 
147: 158. 1943 .. 
9. Goldsmith, G. A., Determination of pyruvic acid in 
thiamin and riboflavin deficiencies. Am. J. Med. 
Sci., 215: 240. 1948. 
10. Havel, R. J., and Watkins, Ee, Jr., The metabolism 
of lactate and pyruvate in children with congenital 
heart disease. Circulation, 11: 536. 1950. 
11. Hepler, o .. E.. Manual of Clinical Laboratorv Methods. 
Springfield, Ill.: Charles C. Thomas, 1950. 
P--
24 
12. Hills, 0, VJ., Marschelle, H. P., and Wilder, R. M .. , 
Diabetes mellitus and Cushing 1 s syndrome. Diabetes, 
1: 151. 1952 .. 
13.. Kleiner, I. S. Human Biochemistrv. St. Louis: C. V. 
Mosby Co., 1952a 
14. Lu, Ee M., Studies of metabolism of pyruvic acid in 
normal and B1 deficient state. Biochem. J., }l: 249. 
l9J9. 
15. Smedley, I. E., and MacLean, J. s .. , Estimation of 
pyruvic acid. Bioch.em. J., 1: 611. 1913 .. 
